NM_000546.6:c.523C>A
Variant summary
The NM_000546.6(TP53):c.523C>A (p.Arg175Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (no review stars). ClinVar reports functional evidence for this variant: "SCV006451527: Studies conducted in human cell lines indicate this alteration is proficient at growth suppression and has no dominant negative effect (Kotler E et al. Mol.Cell. 2018 Jul;71:178-190.e8" and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.R175H: Pathogenic (ClinVar VariationId 12374, 3 stars) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.R175?: Uncertain_significance (ClinVar VariationId 2687679, 0 stars); p.R175C: Uncertain_significance (ClinVar VariationId 245851, 3 stars); p.R175= (synonymous): Benign/Likely_benign (ClinVar VariationId 1527986, 2 stars) A different missense variant at the same amino acid position has been reported as oncogenic in ClinVar. The variant position is a cancer hotspot (cancerhotspots.org) with 2850 samples affected at this amino acid position. This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.
Frequency
Consequence
NM_000546.6 missense
Scores
Clinical Significance
Conservation
Publications
- breast cancerInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
- Li-Fraumeni syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Labcorp Genetics (formerly Invitae)
- Li-Fraumeni syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
- adrenocortical carcinoma, hereditaryInheritance: AD Classification: STRONG Submitted by: Ambry Genetics
- sarcomaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- bone marrow failure syndrome 5Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- colorectal cancerInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- choroid plexus carcinomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Pathogenic. The variant received 13 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PS3Functional studies show damaging effect | Well-established functional study supports damaging effect (PS3); SCV006451527: Studies conducted in human cell lines indicate this alteration is proficient at growth suppression and has no dominant negative effect (Kotler E et al. Mol.Cell. 2018 Jul;71:178-190.e8; Giacomelli AO et al. Nat. Genet. 2018 Oct;50:1381-1387). | ||
| PM1Mutational hot spot or critical domain | Missense neighbourhood hotspot (≥2 P/LP within ±8 AA, OR ≥ 5 vs. background) — PM1; In-domain: 0 pathogenic, 0 benign rare missense variants.; ±8 AA neighbourhood: 38 pathogenic, 5 benign (OR vs. background: 35.0). | ||
| PM2Absent/extremely low in population databases | Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD/XL) (threshold 0.0001) — PM2 moderate. | ||
| PM5Novel missense at known pathogenic residue | Different pathogenic missense at same AA residue in ClinVar (PM5); ClinVar contains a germline Pathogenic/Likely Pathogenic entry at the same amino acid position with a different amino acid change: p.R175H: Pathogenic (ClinVar VariationId 12374, 3 stars); Other variants at the same amino acid residue (not pathogenic): p.R175?: Uncertain_significance (ClinVar VariationId 2687679, 0 stars); p.R175C: Uncertain_significance (ClinVar VariationId 245851, 3 stars); p.R175= (synonymous): Benign/Likely_benign (ClinVar VariationId 1527986, 2 stars) | ||
| PP3Computational evidence supports damaging effect | Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — moderate evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Moderate). | ||
| PP5Reputable source reports pathogenic | ClinVar 0-star pathogenic — supporting (PP5); ClinVar germline classification: Pathogenic/Likely Pathogenic, 0 star(s). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000546.6. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
TP53 | MANE Select | c.523C>A p.Arg175Ser | missense | Exon 5 of 11 | Prot: NP_000537.3 | |
TP53 | c.523C>A p.Arg175Ser | missense | Exon 5 of 11 | Prot: NP_001119584.1 | ||
TP53 | c.523C>A p.Arg175Ser | missense | Exon 6 of 12 | Prot: NP_001394191.1 |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
TP53 | TSL:1MANE Select | c.523C>A p.Arg175Ser | missense | Exon 5 of 11 | Prot: ENSP00000269305.4 UniProt: | |
TP53 | TSL:1 | c.523C>A p.Arg175Ser | missense | Exon 5 of 11 | Prot: ENSP00000391478.2 UniProt: | |
TP53 | TSL:1 | c.406C>A p.Arg136Ser | missense | Exon 4 of 10 | Prot: ENSP00000478219.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 3 sources | |||||
GnomAD3 genomes | Cov:33 | ||||
GnomAD4 exome | Cov:35 | ||||
GnomAD4 genome | Cov:33 | ||||
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 27 | |
AlphaMissense | Pathogenic | 1.0 | |
BayesDel_addAF | Pathogenic | 0.55 | D |
BayesDel_noAF | Pathogenic | 0.55 | |
CADD | Uncertain | 25 | |
DANN | Uncertain | 1.0 | |
DEOGEN2 | Pathogenic | 0.88 | D |
Eigen | Uncertain | 0.44 | |
Eigen_PC | Uncertain | 0.31 | |
FATHMM_MKL | Uncertain | 0.97 | D |
FuncVEP CTI | Pathogenic | 0.92 | |
GPN-Star LLR | N/A | -9.6 | |
GPN-Star score | N/A | 9.6 | |
LIST_S2 | Pathogenic | 0.98 | D |
M_CAP | Pathogenic | 0.90 | D |
MetaRNN | Pathogenic | 0.99 | D |
MetaSVM | Pathogenic | 1.0 | D |
MutationAssessor | Pathogenic | 3.3 | M |
PhyloP100 | Uncertain | 4.0 | |
popEVE | Benign | -4.2 | |
PrimateAI | Uncertain | 0.64 | T |
PromoterAI | N/A | -0.012 | Neutral |
PROVEAN | Pathogenic | -5.8 | D |
RBP_binding_hub_radar | N/A | 0.0 | |
RBP_regulation_power_radar | N/A | 1.1 | |
REVEL | Pathogenic | 0.83 | |
Sift | Pathogenic | 0.0 | D |
Sift4G | Pathogenic | 0.0 | D |
Varity_R | N/A | 0.99 | |
VESM-3B | Benign | -12 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.
MaveDB functional evidence
- Gene
- TP53
- Score
- 0.502